Concepedia

Nicole Wretham

NW

Statistics

Publications

5

Citations

157

H-Index

5

Active since

2020

Affiliations

University of British Columbia(Current)

BC Cancer Agency

Canada's Michael Smith Genome Sciences Centre

BC Innovation Council

Simon Fraser University

Nicole Wretham is an author at University of British Columbia specializing in pharmacy, drug delivery, and pharmacology.

Publications per year

2020–2024

5

Publications

5

TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma

Daisuke Ennishi, Shannon Healy, Ali Bashashati et al. · Nature Medicine · 2020 · 80 citations · Full text

Medicine, Genetics, Oncology +13

Loss of Parkinson’s susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesis

Chandra B Lebovitz, Nicole Wretham, Maryam Osooly et al. · Scientific Reports · 2021 · 35 citations · Full text

Medicine, Genetics, Oncology +17

PEG Conjugated Zein Nanoparticles for In Vivo Use

Courtney van Ballegooie, Nicole Wretham, Tanya Ren et al. · Pharmaceutics · 2022 · 16 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

DMPC/Chol liposomal copper CX5461 is therapeutically superior to a DSPC/Chol formulation

Ada W.Y. Leung, Kent T. J. Chen, Gemma M. Ryan et al. · Journal of Controlled Release · 2022 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

In Vitro and In Vivo Synergetic Radiotherapy with Gold Nanoparticles and Docetaxel for Pancreatic Cancer

Abdulaziz Alhussan, Nolan Jackson, Norman Chow et al. · Pharmaceutics · 2024 · 12 citations · Full text

Medicine, Oncology, Radiation Oncology +17

1–5 of 5